Artificial intelligence (AI) in precision medicine market: Size, Trend and Growth (2025-2034)

Market Overview

The global artificial intelligence (AI) in precision medicine market has gained substantial attention due to the increasing demand for personalized healthcare solutions. Precision medicine, which tailors medical treatment to the individual characteristics of each patient, is greatly enhanced by AI's ability to process vast datasets and predict optimal treatments. AI technologies, such as machine learning and deep learning, are revolutionizing healthcare by analyzing genomic data, medical histories, and lifestyle factors to design specific treatments for patients. This market is expected to expand rapidly due to the growing use of AI in medical research, diagnostics, and therapy development.

Market Size and Share

The  AI in precision medicine market was valued at USD 1.63 billion in 2024. This growth is primarily driven by the increasing demand for personalized treatments and the rising investment in artificial intelligence research and development within the healthcare sector. With a projected compound annual growth rate (CAGR) of 35.6% during the forecast period (2025-2034), the market is expected to grow from USD 2.21 billion in 2025 to USD 25.22 billion by 2034. This robust growth reflects AI’s expanding role in precision medicine, contributing to innovations in disease diagnosis, treatment, and drug development.

Market Trends

AI-Powered Diagnostics
AI algorithms are significantly improving diagnostic accuracy, allowing for early detection of diseases such as cancer, diabetes, and heart disease. AI is able to analyze medical images, patient data, and genetic information to identify patterns that may go unnoticed by human doctors. The integration of AI in diagnostic processes ensures faster and more precise results, reducing human error and leading to more effective treatments.

Advancements in Genomic Medicine
The integration of AI in genomic medicine is a crucial trend within the precision medicine market. AI algorithms are employed to decode complex genomic data, aiding in the identification of gene mutations that contribute to diseases. With the rise of personalized therapies, AI is enabling the development of more targeted treatments that are tailored to an individual’s genetic makeup. This trend is accelerating the transition towards highly personalized and effective medical interventions.

Rising Demand for Personalized Treatment
Patients and healthcare providers are increasingly seeking personalized treatment options, which has created a high demand for precision medicine. AI plays a central role in providing more individualized care by predicting how a patient will respond to various treatments. By analyzing factors such as genetics, lifestyle, and environmental exposure, AI allows for more accurate predictions, resulting in more effective and safer treatments for patients.

Investment in AI-Driven Healthcare Startups
Investment in AI-driven healthcare startups is growing rapidly, as more companies explore the potential of AI in precision medicine. Venture capitalists and pharmaceutical companies are pouring money into startups focused on AI technologies that can enhance medical decision-making and optimize drug development. This trend is contributing to the expansion of the AI in precision medicine market, fostering innovation and bringing new technologies to the forefront of healthcare.

Get a free sample request: https://www.expertmarketresearch.com/reports/artificial-intelligence-in-precision-medicine-market/requestsample

Market Analysis

Healthcare Digitalization
The global shift toward digital healthcare solutions is another key driver in the AI in precision medicine market. The use of electronic health records (EHRs), health information systems, and digital diagnostics is accelerating the implementation of AI technologies in healthcare. By analyzing patient data from these digital systems, AI can identify health risks and predict potential medical conditions, paving the way for timely and preventive treatments.

Regulatory Developments
Regulatory bodies are playing a significant role in the growth of AI in precision medicine by ensuring that AI technologies are safe and effective. The FDA has recently approved AI-based medical devices and algorithms for clinical use, establishing a regulatory framework for AI integration. The adoption of clear regulations and guidelines is helping to build trust in AI technologies and supporting their widespread application in medicine.

Technological Advancements
The continuous advancement of AI technologies, including machine learning, natural language processing (NLP), and big data analytics, is reshaping the precision medicine landscape. These innovations enable healthcare providers to analyze large volumes of complex data quickly and accurately, leading to better decision-making. As technology evolves, AI will continue to push the boundaries of personalized healthcare, allowing for faster treatments and more efficient healthcare delivery.

Collaborations and Partnerships
Collaborations between AI companies, pharmaceutical firms, and research institutions are fostering rapid growth in the precision medicine market. By partnering with AI-driven technology providers, pharmaceutical companies can accelerate drug development processes, enhance clinical trials, and develop more precise treatments. These partnerships are creating new opportunities for the integration of AI into various aspects of medicine, further expanding the scope of precision medicine.

Market Segmentation

Market Breakup by Disease Type

• Active Tuberculosis
  AI technologies are being increasingly used to identify and manage active tuberculosis (TB). With AI-powered diagnostic tools, clinicians can quickly detect TB infections in patients and determine the most effective treatment plans. By analyzing patient data, AI can also help predict the spread of active TB, enabling more targeted interventions and reducing transmission rates.
• Latent Tuberculosis
  AI is also revolutionizing the management of latent tuberculosis (LTBI) by offering insights into the risks and potential progression of the disease. AI algorithms can analyze patient history, genetic predisposition, and other factors to predict which individuals are at risk of developing active TB. This helps in tailoring preventive strategies and ensuring timely interventions for those at highest risk.

Market Breakup by Therapy Type

• First Line Therapy
  First-line therapies are the primary treatment option for many infectious diseases, including TB. AI technologies are being used to analyze the effectiveness of first-line drugs in different patient populations, optimizing the prescription process. AI’s ability to predict treatment outcomes enables healthcare providers to make better-informed decisions and reduce the risk of drug resistance.
• Second Line Therapy
  Second-line therapies are used when first-line treatments fail or are contraindicated. AI is instrumental in identifying alternative drug combinations and personalizing treatment plans based on patient data. By analyzing vast amounts of clinical and genetic data, AI helps in selecting the most effective second-line drugs, improving patient outcomes and reducing healthcare costs.

Market Breakup by Route of Administration

• Oral
  Oral administration remains one of the most common and convenient routes for drug delivery. AI helps in the development of oral formulations that maximize drug bioavailability and patient compliance. By simulating the effects of oral drugs within the body, AI can optimize formulations and provide more effective and personalized treatment options for patients.
• Parenteral
  Parenteral administration, including injections and infusions, is often used for drugs that cannot be taken orally. AI is being used to refine the delivery mechanisms for parenteral drugs, ensuring optimal drug release and absorption. AI can also assist in determining the best injection sites and administering doses, improving the efficiency of parenteral treatments.
• Others
  In addition to oral and parenteral routes, other drug administration methods, such as transdermal, ocular, and pulmonary routes, are gaining traction. AI technologies are helping to optimize these alternative routes by analyzing their impact on drug absorption and efficacy. AI-powered systems are enabling more precise delivery, offering patients a wider range of treatment options.

Market Breakup by Dosage Form

• Tablets
  Tablets remain a popular dosage form, particularly for chronic diseases. AI is used in the design and development of tablet formulations that offer controlled release and enhanced stability. By predicting the pharmacokinetics of drugs, AI ensures that tablets provide consistent therapeutic effects over time, improving patient outcomes.
• Capsules
  Capsules, another popular oral dosage form, are increasingly being optimized with the help of AI. AI algorithms assist in determining the best capsule formulations, ensuring that the drug is delivered in the most effective and patient-friendly way. This is especially important for drugs with specific absorption requirements or those that need to be protected from stomach acid.
• Injections
  Injectable drugs are used when rapid absorption is required or when oral administration is not feasible. AI is enhancing the development of injectable drugs by predicting how the body will respond to different formulations. By analyzing clinical data, AI helps optimize injection techniques and dosage regimens for better patient outcomes.
• Others
  In addition to tablets, capsules, and injections, other dosage forms, such as transdermal patches, oral suspensions, and inhalers, are gaining popularity. AI is supporting the development of these alternative forms by analyzing patient preferences, pharmacokinetics, and the best delivery methods for each specific drug.

Market Breakup by Distribution Channel

• Hospital Pharmacy
  Hospital pharmacies remain a primary distribution channel for precision medicines. AI is helping optimize inventory management, improve drug selection processes, and streamline the prescription process. By leveraging AI in hospital settings, healthcare providers can ensure that patients receive the most effective treatments in a timely manner.
• Retail Pharmacy
  Retail pharmacies are also crucial in the distribution of precision medicines. AI technologies are being used to monitor drug availability and predict which medications will be in demand. Additionally, AI-powered tools help retail pharmacies enhance customer service by recommending personalized treatment options based on patient data.
• Online Pharmacy
  The growth of online pharmacies is providing patients with greater access to precision medicines. AI helps optimize the supply chain, ensuring that medications are delivered efficiently and securely. Moreover, AI systems in online pharmacies can analyze patient profiles to offer tailored recommendations, improving patient satisfaction and treatment outcomes.

Regional Insights

North America
North America holds a significant share in the AI in precision medicine market due to the advanced healthcare infrastructure, high adoption of AI technologies, and strong research and development (R&D) investments. The U.S., in particular, is a major hub for AI-driven healthcare innovations, with a large number of biotech and pharmaceutical companies focusing on personalized treatments.

Europe
Europe is witnessing steady growth in the AI in precision medicine market. Countries such as Germany, the U.K., and France are investing in AI technologies for disease diagnosis and drug development. The European Union is also implementing regulatory frameworks to support the integration of AI in healthcare, creating a favorable environment for market expansion.

Asia Pacific
The Asia Pacific region is expected to experience the highest growth rate in the AI in precision medicine market. Emerging economies like China, India, and Japan are focusing on expanding their healthcare systems and adopting AI technologies to improve patient care. The growing healthcare expenditure and increasing demand for personalized treatment options contribute to the region's rapid growth.

Latin America, Middle East, and Africa
The Latin America, Middle East, and Africa (LAMEA) regions are gradually adopting AI in precision medicine, but the growth is relatively slower compared to other regions. However, increasing awareness, technological advancements, and government initiatives aimed at improving healthcare accessibility are expected to drive market expansion in these regions in the coming years.

Market Growth

The AI in precision medicine market is poised for rapid growth due to several key factors. Rising healthcare costs, the increasing prevalence of chronic diseases, and the need for personalized treatments are major drivers. Additionally, technological advancements in AI, including machine learning, deep learning, and natural language processing, are providing new opportunities to enhance patient care and drug development. Investments in AI research and collaborations between healthcare providers, pharmaceutical companies, and tech firms are expected to further fuel market growth.

Recent Developments & Challenges

• FDA Approvals for AI-based Diagnostics: The U.S. FDA recently approved several AI-driven diagnostic tools for clinical use, enhancing the role of AI in precision medicine.
• Innovations in Drug Discovery: AI technologies are accelerating drug discovery, with companies using machine learning algorithms to predict the efficacy of potential drug candidates.
• Regulatory Challenges: As AI technologies continue to evolve, regulators face challenges in keeping up with the pace of innovation. Establishing clear guidelines for AI applications in healthcare remains a priority.
• Data Privacy Concerns: With the increasing use of patient data in AI algorithms, concerns over data privacy and security are a challenge for the industry.

Key Players

Novo Nordisk A/S
Novo Nordisk is a leader in the global healthcare sector, specializing in diabetes and other chronic diseases. The company is leveraging AI to enhance drug discovery and patient care, particularly in precision medicine. By investing in AI technologies, Novo Nordisk aims to develop more personalized treatment options for diabetes and other metabolic disorders.

GE Healthcare
GE Healthcare is at the forefront of AI in medical imaging and diagnostics. The company’s AI-driven solutions, such as its imaging software, help clinicians make faster, more accurate diagnoses. GE Healthcare's commitment to AI in precision medicine is reshaping the way doctors approach patient care, especially in areas like oncology.

Intel Corporation
Intel is investing heavily in AI-driven solutions for healthcare, focusing on precision medicine. The company’s AI technologies are designed to enhance medical research, improve diagnostic processes, and enable faster drug development. Intel’s AI-powered computing platforms are helping researchers and healthcare professionals achieve more accurate and efficient results.

NVIDIA Corporation
NVIDIA is a key player in the AI market, providing high-performance computing solutions for healthcare. Its GPUs are widely used in AI-powered medical research and drug discovery. NVIDIA’s AI technologies are driving innovation in precision medicine, particularly in the areas of genomics, imaging, and predictive analytics.

Other key players in the market include Microsoft Corporation, Alphabet Inc., IBM Corporation, Enlitic Inc., AstraZeneca, and Sanofi.

FAQs

. What is precision medicine?
Precision medicine is an innovative approach to healthcare that tailors treatments based on individual patient characteristics, such as their genetics, lifestyle, and environment.

. How does AI contribute to precision medicine?
AI helps process vast amounts of data, including medical records and genetic information, to predict the most effective treatments for individual patients, thereby improving health outcomes.

. What are the growth prospects of the AI in precision medicine market?
The market is expected to grow at a CAGR of 35.6% from 2025 to 2034, with significant investments in AI technologies driving its expansion.

. Which regions are leading the AI in precision medicine market?
North America leads the market due to strong technological advancements, followed by Europe and the Asia Pacific, which are experiencing rapid growth in the adoption of AI technologies.